CARISOPRODOL

Post-LOE

carisoprodol

Evergreen Therapeutics
ANDAORALTABLET
Approved
Oct 2014
Lifecycle
Post-LOE
Competitive Pressure
30/100
Company
ET
Evergreen Therapeutics
China - Hong Kong
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers